Researchers find genetic variation that lowers effect of cholesterol drugs

A U.S. study of 1,500 people treated with statins found those who had a common genetic variation affecting how they synthesize cholesterol had a total cholesterol reduction that was 22% smaller than others after six months. The researchers said their findings could result in pharmacogenetic screening that would help doctors prescribe the right dosage of statin medicine for their patients.

View Full Article in:

Reuters · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL